12:00 AM
May 17, 1999
 |  BC Week In Review  |  Company News  |  Deals

Inflazyme, Hoechst Marion Roussel Inc. deal

The companies finalized their previously announced letter of intent to develop compounds to treat allergies, asthma and respiratory diseases using compounds from IZP's IPL576...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >